Xeris Biopharma Holdings, Inc. (XERS) Insider Trading

Name: Xeris Biopharma Holdings, Inc. (XERS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Steven Pieper (Chief Financial Officer): Sale of 5,000 shares, $47.0K.

Get alerted when insiders trade XERS

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta